Langer Dennis
- SEC CIK
- 0001274225
In the past year, 1 open-market purchase filing worth $128.6K and no sales.
Current role at each company
- QNRX Quoin Pharmaceuticals Ltd.Directoras of Aug 28, 2026
- MYGN Myriad Genetics IncDirectoras of Jun 30, 2022
- ERNA Ernexa Therapeutics Inc.Directoras of Dec 10, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $128.6K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$128.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Langer Dennis as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QNRX Quoin Pharmaceuticals Ltd.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 (view filing) | Jun 7 | 3 days | Langer DennisDirector | SSale | −297 | $0.73 | −$216.81 | −84.9%53 after | |
| Oct 15, 2025 (view filing) | Oct 14 | 1 day | Langer DennisDirector | PPurchaseADSs | +15.2K | $8.49 | +$128.6K | +1,515,200.0%15.2K after | |
| Oct 15, 2025 (view filing) | Oct 14 | 1 day | Langer DennisDirector | PPurchaseADS | +60.6K | – | – | –15.2K after | Derivative4 lots |
MYGN Myriad Genetics Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Langer DennisDirector | SSale | −30.0K | $34.75 | −$1.04M | −25.1%89.5K after |